Literature DB >> 29174597

Intravascular hemolysis in patients with mitral regurgitation: Evaluation by erythrocyte creatine.

Tetsuro Sugiura1, Toshika Okumiya2, Mikio Kamioka3, Toru Kubo4, Yoko Hirakawa4, Taisuke Hisahara1, Yoshihisa Matsumura1.   

Abstract

BACKGROUND: Intravascular hemolysis has been reported in patients with cardiac valve prostheses, but intravascular hemolysis in patients with mitral regurgitation with native valve has not been evaluated in detail. We designed a study to elucidate the impact of regurgitation flow on intravascular hemolysis in patients with primary mitral regurgitation by measuring erythrocyte creatine.
METHODS: Erythrocyte creatine was enzymatically assayed in 29 patients with moderate to severe primary mitral regurgitation and 12 age-matched healthy volunteers. The size and characteristics of mitral regurgitation were determined by color Doppler echocardiography.
RESULTS: Erythrocyte creatine was significantly higher in patients with eccentric jet (n=17, 2.64±0.77μmol/g Hb) than that of central jet (n=12, 1.68±0.13μmol/g Hb) and control subjects (1.39±0.25μmol/g Hb). Patients with eccentric jet had a significantly lower erythrocyte count and hemoglobin (385±58 x104/μL and 116±19g/l) compared to those with central jet (450±47×104/μL and 137±14g/l) and control subjects (433±31×104/μL and 134±19g/l). There were no significant differences in age, estimated glomerular filtration rate, pulmonary artery systolic pressure, left atrial size and left ventricular end-diastolic dimension between patients with eccentric jet and central jet.
CONCLUSIONS: Intravascular hemolysis associated with subclincal anemia in patients with eccentric jet was due to the destruction of erythrocyte by collision of the eccentric jet to the atrial wall.
Copyright © 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Erythrocyte age; Erythrocyte creatine; Intravascular hemolysis; Mitral regurgitation

Mesh:

Substances:

Year:  2017        PMID: 29174597     DOI: 10.1016/j.jjcc.2017.10.006

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  1 in total

1.  Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients.

Authors:  Shun Hasegawa; Seishi Nakamura; Tetsuro Sugiura; Yoshiaki Tsuka; Nobuyuki Takahashi; Koichiro Matsumura; Toshika Okumiya; Masato Baden; Ichiro Shiojima
Journal:  BMC Nephrol       Date:  2021-12-12       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.